|
|
(13 intermediate revisions by 8 users not shown) |
label / ast | label / ast |
| | The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. |
description / pt | description / pt |
| artigo científico | | artigo científico (publicado na 2011) |
description / pt-br | description / pt-br |
| artigo científico | | artigo científico (publicado na 2011) |
description / hy | description / hy |
| գիտական հոդված | | 2011 թվականի օգոստոսին հրատարակված գիտական հոդված |
description / ast | description / ast |
| artículu científicu | | artículu científicu espublizáu en 2011 |
description / da | description / da |
| videnskabelig artikel | | videnskabelig artikel (udgivet 2011) |
description / fr | description / fr |
| article scientifique | | article scientifique (publié 2011) |
description / hyw | description / hyw |
| | 2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած |
description / ml | description / ml |
| | ശാസ്ത്രപ്രബന്ധം |
description / ur | description / ur |
| | سائنسی مضمون |
description / fa | description / fa |
| | مقالهٔ علمی |
| Property / publication date: 1 August 2011 / reference |
| | |
Property / publication date: 1 August 2011 / reference | |
| | |
| Property / instance of: scholarly article / reference |
| | |
Property / instance of: scholarly article / reference | |
| | |
| Property / DOI: 10.1016/S0140-6736(11)61126-4 / reference |
| | |
Property / DOI: 10.1016/S0140-6736(11)61126-4 / reference | |
| | |
| Property / volume: 378 / reference |
| | |
Property / volume: 378 / reference | |
| | |
Property / title | |
| The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. (English)
| |
Property / title: The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. (English) / rank | |
| Normal rank
| |
Property / title: The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. (English) / reference | |
| | |
| Property / issue: 9792 / reference |
| | |
Property / issue: 9792 / reference | |
| | |
| Property / published in: The Lancet / reference |
| | |
Property / published in: The Lancet / reference | |
| | |
Property / author name string | |
| John G F Cleland
| |
Property / author name string: John G F Cleland / rank | |
| Normal rank
| |
Property / author name string: John G F Cleland / qualifier | |
| | |
Property / author name string: John G F Cleland / reference | |
| | |
Property / author name string | |
| John R Teerlink
| |
Property / author name string: John R Teerlink / rank | |
| Normal rank
| |
Property / author name string: John R Teerlink / qualifier | |
| | |
Property / author name string: John R Teerlink / reference | |
| | |
Property / author name string | |
| Roxy Senior
| |
Property / author name string: Roxy Senior / rank | |
| Normal rank
| |
Property / author name string: Roxy Senior / qualifier | |
| | |
Property / author name string: Roxy Senior / reference | |
| | |
| Property / author name string: Evgeny M Nifontov / reference |
| | |
Property / author name string: Evgeny M Nifontov / reference | |
| | |
Property / author name string | |
| John J V Mc Murray
| |
Property / author name string: John J V Mc Murray / rank | |
| Normal rank
| |
Property / author name string: John J V Mc Murray / qualifier | |
| | |
Property / author name string: John J V Mc Murray / reference | |
| | |
| Property / author name string: Vitaly A Tsyrlin / reference |
| | |
Property / author name string: Vitaly A Tsyrlin / reference | |
| | |
Property / author name string | |
| Barry H Greenberg
| |
Property / author name string: Barry H Greenberg / rank | |
| Normal rank
| |
Property / author name string: Barry H Greenberg / qualifier | |
| | |
Property / author name string: Barry H Greenberg / reference | |
| | |
| Property / author name string: Jamil Mayet / reference |
| | |
Property / author name string: Jamil Mayet / reference | |
| | |
| Property / author name string: Darrel P Francis / reference |
| | |
Property / author name string: Darrel P Francis / reference | |
| | |
| Property / author name string: Tamaz Shaburishvili / reference |
| | |
Property / author name string: Tamaz Shaburishvili / reference | |
| | |
| Property / author name string: Mark Monaghan / reference |
| | |
Property / author name string: Mark Monaghan / reference | |
| | |
| Property / author name string: Mitchell Saltzberg / reference |
| | |
Property / author name string: Mitchell Saltzberg / reference | |
| | |
Property / author name string | |
| Ludwig Neyses
| |
Property / author name string: Ludwig Neyses / rank | |
| Normal rank
| |
Property / author name string: Ludwig Neyses / qualifier | |
| | |
Property / author name string: Ludwig Neyses / reference | |
| | |
Property / author name string | |
| Scott M Wasserman
| |
Property / author name string: Scott M Wasserman / rank | |
| Normal rank
| |
Property / author name string: Scott M Wasserman / qualifier | |
| | |
Property / author name string: Scott M Wasserman / reference | |
| | |
| Property / author name string: Jacqueline H Lee / reference |
| | |
Property / author name string: Jacqueline H Lee / reference | |
| | |
| Property / author name string: Khalil G Saikali / reference |
| | |
Property / author name string: Khalil G Saikali / reference | |
| | |
| Property / author name string: Cyril P Clarke / reference |
| | |
Property / author name string: Cyril P Clarke / reference | |
| | |
| Property / author name string: Jonathan H Goldman / reference |
| | |
Property / author name string: Jonathan H Goldman / reference | |
| | |
| Property / author name string: Andrew A Wolff / reference |
| | |
Property / author name string: Andrew A Wolff / reference | |
| | |
Property / author name string | |
| Fady I Malik
| |
Property / author name string: Fady I Malik / rank | |
| Normal rank
| |
Property / author name string: Fady I Malik / qualifier | |
| | |
Property / author name string: Fady I Malik / reference | |
| | |
| Property / page(s): 676-683 / reference |
| | |
Property / page(s): 676-683 / reference | |
| | |
| Property / PubMed publication ID: 21856481 / reference |
| | |
Property / PubMed publication ID: 21856481 / reference | |
| | |
Property / author | |
| | |
Property / author: Chim C. Lang / rank | |
| Normal rank
| |
Property / author: Chim C. Lang / qualifier | |
| | |
Property / author: Chim C. Lang / qualifier | |
| | |
| Property / main subject |
| | |
| Property / main subject: systole / rank |
| | Normal rank |
| Property / main subject: systole / reference |
| | |
| Property / main subject |
| | |
| Property / main subject: systolic heart failure / rank |
| | Normal rank |
| Property / main subject: systolic heart failure / reference |
| | |
| Property / title |
| | The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial (English) |
| Property / title: The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial (English) / rank |
| | Normal rank |
| Property / title: The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial (English) / reference |
| | |
| Property / author |
| | |
| Property / author: John Cleland / rank |
| | Normal rank |
| Property / author: John Cleland / qualifier |
| | |
| Property / author: John Cleland / reference |
| | |
| Property / author |
| | |
| Property / author: John McMurray / rank |
| | Normal rank |
| Property / author: John McMurray / qualifier |
| | |
| Property / author: John McMurray / reference |
| | |
| Property / author |
| | |
| Property / author: Chim C. Lang / rank |
| | Normal rank |
| Property / author: Chim C. Lang / qualifier |
| | |
| Property / author: Chim C. Lang / reference |
| | |
| Property / author |
| | |
| Property / author: John R Teerlink / rank |
| | Normal rank |
| Property / author: John R Teerlink / qualifier |
| | |
| Property / author: John R Teerlink / qualifier |
| | |
| Property / author: John R Teerlink / reference |
| | |
| Property / author |
| | |
| Property / author: Roxy Senior / rank |
| | Normal rank |
| Property / author: Roxy Senior / qualifier |
| | |
| Property / author: Roxy Senior / qualifier |
| | |
| Property / author: Roxy Senior / reference |
| | |
| Property / author |
| | |
| Property / author: Barry H. Greenberg / rank |
| | Normal rank |
| Property / author: Barry H. Greenberg / qualifier |
| | |
| Property / author: Barry H. Greenberg / qualifier |
| | |
| Property / author: Barry H. Greenberg / reference |
| | |
| Property / author |
| | |
| Property / author: Fady I Malik / rank |
| | Normal rank |
| Property / author: Fady I Malik / qualifier |
| | |
| Property / author: Fady I Malik / qualifier |
| | |
| Property / author: Fady I Malik / reference |
| | |
| Property / author |
| | |
| Property / author: Scott M. Wasserman / rank |
| | Normal rank |
| Property / author: Scott M. Wasserman / qualifier |
| | |
| Property / author: Scott M. Wasserman / qualifier |
| | |
| Property / author: Scott M. Wasserman / reference |
| | |
| Property / author |
| | |
| Property / author: Ludwig Neyses / rank |
| | Normal rank |
| Property / author: Ludwig Neyses / qualifier |
| | |
| Property / author: Ludwig Neyses / qualifier |
| | |
| Property / author: Ludwig Neyses / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Clinical practice. Systolic heart failure. / rank |
| | Normal rank |
| Property / cites work: Clinical practice. Systolic heart failure. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs / rank |
| | Normal rank |
| Property / cites work: Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Cardiac myosin activation: a potential therapeutic approach for systolic heart failure / rank |
| | Normal rank |
| Property / cites work: Cardiac myosin activation: a potential therapeutic approach for systolic heart failure / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure / rank |
| | Normal rank |
| Property / cites work: Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: The failing heart--an engine out of fuel / rank |
| | Normal rank |
| Property / cites work: The failing heart--an engine out of fuel / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure / rank |
| | Normal rank |
| Property / cites work: Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Sarcomeric proteins and inherited cardiomyopathies. / rank |
| | Normal rank |
| Property / cites work: Sarcomeric proteins and inherited cardiomyopathies. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study / rank |
| | Normal rank |
| Property / cites work: Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial / rank |
| | Normal rank |
| Property / cites work: Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators / rank |
| | Normal rank |
| Property / cites work: A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy / rank |
| | Normal rank |
| Property / cites work: Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: The effect of cardiac resynchronization on morbidity and mortality in heart failure / rank |
| | Normal rank |
| Property / cites work: The effect of cardiac resynchronization on morbidity and mortality in heart failure / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Cardiac-resynchronization therapy for the prevention of heart-failure events / rank |
| | Normal rank |
| Property / cites work: Cardiac-resynchronization therapy for the prevention of heart-failure events / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Lack of desensitization and enhanced efficiency of calcium channel promoter in conscious dogs with heart failure. / rank |
| | Normal rank |
| Property / cites work: Lack of desensitization and enhanced efficiency of calcium channel promoter in conscious dogs with heart failure. / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators / rank |
| | Normal rank |
| Property / cites work: Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators / reference |
| | |
| Property / cites work |
| | |
| Property / cites work: Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy / rank |
| | Normal rank |
| Property / cites work: Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy / reference |
| | |